🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase I/II trial studies the safety and effectiveness of lenalidomide ...
Status
Completed
Location
University of Chicago
Start Date
2013-10-17
Trial ID
NCT01838434
Treatments Being Tested
Rosai-Dorfman Disease (RDD) is a rare, heterogeneous histiocytic disorder. ...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2021-06-08
Trial ID
NCT04924647
Treatments Being Tested
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
The purpose of this study is to quantify the burden of treatment in relapse...
Status
Completed
Location
Karolinska Institute
Start Date
2010-11
Trial ID
NCT01430546
Recent prospective multicenter phase II study assessed the efficacy and tol...
Status
Unknown
Location
Kosin University Gospel Hospital
Start Date
2019-03-11
Trial ID
NCT03809780
Treatments Being Tested
This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT03283046
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
This randomized phase III trial compares ixazomib citrate, lenalidomide, de...
Status
Terminated
Location
Anchorage Associates in Radiation Medicine
Start Date
2016-11-29
Trial ID
NCT02516423
Treatments Being Tested
This is a Phase 1/2, open-label, monocentric, dose-escalation study of lena...
Status
Unknown
Location
Medical University of Innsbruck, Department for Internal Medicine I
Start Date
2010-03
Trial ID
NCT01166035
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720